Ashesh Jani, MD, MSEE, FASTRO

One star
One star
One star
One star
One half star

Rating: 4.9 out of 5 (227 ratings)

Role

Radiation Oncology
Specialty

Bladder Cancer Kidney (Renal) Cancer Penile Cancer Prostate Cancer Testicular Cancer
Research Program

Cancer Prevention and Control
Practicing Since

2000

Call 404-778-3473

Background

Ashesh B. Jani, MD, MSEE, FASTRO, is a board certified radiation oncologist in the Department of Radiation Oncology at Emory University School of Medicine in Atlanta, GA. Dr. Jani practices general radiation oncology and specializes in the treatment of prostate, bladder, kidney, and testicular cancer. He treats patients at Winship Cancer Institute of Emory University.

Dr. Jani was born in India and moved to Chicago, Illinois, at the age of three. He is married and has twin boys. He is an avid sports fan, particularly of tennis and NFL. He enjoys spending time with his family, playing tennis, watching movies and traveling. He has traveled throughout the US, to 49 states, and has visited 9 other countries.

Titles & Roles

Professor, Department of Radiation Oncology

Emory University School of Medicine
James C. Kennedy Professor in Prostate Cancer

Winship Cancer Institute of Emory University

Education & Training

Education

Residency, Radiation Oncology, 2000
The University of Chicago Medicine
Internship, Internal Medicine, 1996
Rush Presbyterian - St. Lukes Med Center
Medical Education, MD, 1995
University of Illinois at Chicago

Board Certifications

Radiation Oncology
American Board of Radiology, 2001

Professional Memberships

American College of Radiology
American Medical Association
American Society for Therapeutic Radiology and Oncology
American Society of Clinical Oncology
Radiological Society of North America

Research

View Current Clinical Trials


Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial Phase III Conditions Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Location Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Emory Johns Creek Hospital, Emory Proton Therapy Center, Grady Health System, Winship Cancer Institute

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
- Phase
  
  III
- Conditions
  
  Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8
- Location
  
  Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Emory Johns Creek Hospital, Emory Proton Therapy Center, Grady Health System, Winship Cancer Institute

Grants

View Grants

Grant Number	Title
5K12CA237806-05	Emory Clinical Oncology Career Development Award K12 Program

Publications

Title/Journal	Authors	Publication Date
Utilization, health care expenditures, and patient costs of definitive treatment modalities for localized prostate cancer in the United States. Cancer	NT Sebastian, D Patil, PR Patel, AB Jani, BW Hershatter, VR Dhere, KD Godette, CA Lorentz, AD Weiss, SS Joshi, MG Sanda, SA Patel	03/15/2025
Diuresis During ¹⁸F-Flotufolastat (rhPSMA-7.3) PET/CT Improves Recurrence Detection After Prostatectomy: A Prospective Phase II Trial. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	IO Lawal, A Mushtaq, AB Jani, M Rupji, VR Dhere, SA Patel, MA Bilen, PR Patel, NT Sebastian, JM Switchenko, DM Schuster, C Marcus	02/03/2025
Characteristics, Treatment, and Outcomes of Primary Urethral Cancer: A Multicenter Review Over Two Decades. Clinical genitourinary cancer	BD Hopkins, DC Qian, KM Xu, A McCook-Veal, J Switchenko, LM Hartsell, CB Cimmino, SS Joshi, V Narayan, VA Master, B Nazha, BC Carthon, MA Bilen, O Kucuk, JW Shelton, PR Patel, AB Jani, JS Remick, TY Eng	02/01/2025
Cross-shaped windows transformer with self-supervised pretraining for clinically significant prostate cancer detection in bi-parametric MRI. Medical physics	Y Li, J Wynne, J Wang, RLJ Qiu, J Roper, S Pan, AB Jani, T Liu, PR Patel, H Mao, X Yang	02/01/2025
Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer-Updated Report of NRG/RTOG 0712: A Randomized Phase 2 Trial. International journal of radiation oncology, biology, physics	JJ Coen, JP Rodgers, PJ Saylor, CT Lee, CL Wu, W Parker, T Lautenschlaeger, AL Zietman, J Efstathiou, AB Jani, O Kucuk, L Souhami, SL Pugh, HM Sandler, WU Shipley	01/01/2025
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	DM Dahl, JP Rodgers, WU Shipley, MD Michaelson, CL Wu, W Parker, AB Jani, FL Cury, RS Hudes, JM Michalski, AC Hartford, D Song, DE Citrin, TG Karrison, HM Sandler, FY Feng, JA Efstathiou	12/01/2024
PPV of Bone Uptake of ¹⁸F-Flotufolastat: Evaluation Using SPOTLIGHT Study Data. AJR. American journal of roentgenology	DM Schuster, AB Jani, CV Marcus, A Chau, P Davis	11/01/2024
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712. European urology oncology	Z Rana, SC Kamran, AC Shetty, P Sutera, Y Song, S Bazyar, AA Solanki, JP Simko, A Pollack, D McConkey, M Kates, MM Siddiqui, J Hiken, J Earls, D Messina, KW Mouw, D Miyamoto, WU Shipley, MD Michaelson, A Zietman, JJ Coen, DM Dahl, AB Jani, L Souhami, BK Chang, RJ Lee, H Pham, DT Marshall, X Shen, SL Pugh, FY Feng, JA Efstathiou, PT Tran, MP Deek	10/01/2024
Impact of Rectal Spacer on Toxicity Reduction in Men Treated With Proton Versus Photon Therapy. International journal of particle therapy	VR Dhere, S Goyal, J Zhou, NT Sebastian, AB Patel, S Hanasoge, PR Patel, J Shelton, KD Godette, BW Hershatter, AB Jani, SA Patel	09/01/2024
Secondary Cancer in Prostate Cancer Patients Treated With Advanced External Beam Radiation Therapy. International journal of particle therapy	SE Kulkarni, SA Patel, Y Sun, AB Jani, TW Gillespie, MW McDonald, Y Liu	09/01/2024
Impact of Clinical Factors on ¹⁸F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study. Advances in radiation oncology	BH Lowentritt, AB Jani, BT Helfand, EM Uchio, MA Morris, JM Michalski, A Chau, P Davis, BF Chapin, DM Schuster	08/01/2024
Impact of androgen deprivation therapy in patients with unfavorable intermediate-risk prostate cancer receiving brachytherapy-based dose-escalated radiation therapy. Journal of contemporary brachytherapy	NT Sebastian, S Goyal, Y Liu, V Dhere, AB Jani, B Hershatter, PR Patel, JW Shelton, S Hanasoge, KD Godette, SA Patel	08/01/2024
Biochemical Relapse-Free Survival in Postprostatectomy Patients Receiving 18F-Fluciclovine-Guided Prostate Bed-Only Radiation: Post Hoc Analysis of a Prospective Randomized Trial. Practical radiation oncology	VR Dhere, DM Schuster, S Goyal, E Schreibmann, BW Hershatter, SA Patel, JW Shelton, S Hanasoge, PR Patel, NT Sebastian, OA Adediran, IO Lawal, AB Jani	01/01/2024
Prostate Cancer Skeletal Metastasis: A Spontaneous Evolution from Osteolytic to Osteoblastic Morphology without Treatment. World journal of nuclear medicine	IO Lawal, MA Bilen, RK Halkar, AB Jani, DM Schuster	12/01/2023
Rapid unpaired CBCT-based synthetic CT for CBCT-guided adaptive radiotherapy. Journal of applied clinical medical physics	JF Wynne, Y Lei, S Pan, T Wang, M Pasha, K Luca, J Roper, P Patel, SA Patel, K Godette, AB Jani, X Yang	10/01/2023
Association of Radiation Facility Volume with Overall Survival in Patients with Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy. International journal of radiation oncology, biology, physics	N Sebastian, S Goyal, Y Liu, PR Patel, S Hanasoge, VR Dhere, JW Shelton, KD Godette, A Jani, B Hershatter, B Fischer-Valuck, SA Patel	10/01/2023
Biochemical Relapse-Free Survival in Post-Prostatectomy Patients Receiving ¹⁸F-Fluciclovine-Guided Prostate Bed Only Radiation: Post-Hoc Analysis of a Prospective Randomized Trial. International journal of radiation oncology, biology, physics	VR Dhere, DM Schuster, S Goyal, E Schreibmann, B Hershatter, SA Patel, JW Shelton, S Hanasoge, PR Patel, N Sebastian, IO Lawal, A Jani	10/01/2023
Aberrant Vascular Anatomy Associated With Artifactual Focal Avidity in the Liver on PSMA PET. Clinical nuclear medicine	IO Lawal, M Pectasides, AS Parihar, HU Shah, RK Halkar, AB Jani, DM Schuster	09/01/2023
Automatic segmentation of neurovascular bundle on mri using deep learning based topological modulated network. Medical physics	Y Lei, T Wang, J Roper, S Tian, P Patel, JD Bradley, AB Jani, T Liu, X Yang	09/01/2023
Diagnostic Performance and Safety of ¹⁸F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply. The Journal of urology	AB Jani, GC Ravizzini, BA Gartrell, BA Siegel, P Twardowski, D Saltzstein, MT Fleming, A Chau, P Davis, BF Chapin, DM Schuster	09/01/2023
Radiation Facility Volume and Survival for Men With Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy. JAMA network open	N Sebastian, S Goyal, Y Liu, JR Janopaul-Naylor, PR Patel, VR Dhere, S Hanasoge, JW Shelton, KD Godette, AB Jani, B Hershatter, B Fischer-Valuck, SA Patel	08/01/2023
Diagnostic Performance and Safety of ¹⁸F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). The Journal of urology	AB Jani, GC Ravizzini, BA Gartrell, BA Siegel, P Twardowski, D Saltzstein, MT Fleming, A Chau, P Davis, BF Chapin, DM Schuster	08/01/2023
Reply by Authors. The Journal of urology	AB Jani, GC Ravizzini, BA Gartrell, BA Siegel, P Twardowski, D Saltzstein, MT Fleming, A Chau, P Davis, BF Chapin, DM Schuster	08/01/2023
Plan Quality Analysis of Automated Treatment Planning Workflow With Commercial Auto-Segmentation Tools and Clinical Knowledge-Based Planning Models for Prostate Cancer. Cureus	J Adams, K Luca, X Yang, P Patel, A Jani, J Roper, J Zhang	07/01/2023
Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer. Urologic oncology	SA Patel, Y Liu, AA Solanki, BC Baumann, JA Efstathiou, AB Jani, AJ Chang, B Fischer-Valuck, TJ Royce	07/01/2023
Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy. Clinical nuclear medicine	IO Lawal, C Marcus, DM Schuster, S Goyal, OA Adediran, VR Dhere, SS Joshi, OA Abiodun-Ojo, VA Master, PR Patel, B Fielder, M Goodman, JW Shelton, O Kucuk, B Hershatter, RK Halkar, AB Jani	04/01/2023
Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus ¹⁸F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	IO Lawal, AB Jani, OA Adediran, S Goyal, OA Abiodun-Ojo, VR Dhere, CV Marcus, SS Joshi, VA Master, PR Patel, M Goodman, JW Shelton, O Kucuk, B Hershatter, B Fielder, RK Halkar, DM Schuster	04/01/2023
Challenges and opportunities in the management of non-urothelial bladder cancers. Cancer treatment and research communications	JT Brown, VM Narayan, SS Joshi, L Harik, AB Jani, MA Bilen	01/01/2023
Lesion segmentation on ¹⁸F-fluciclovine PET/CT images using deep learning. Frontiers in oncology	T Wang, Y Lei, E Schreibmann, J Roper, T Liu, DM Schuster, AB Jani, X Yang	01/01/2023
Male pelvic multi-organ segmentation using token-based transformer Vnet. Physics in medicine and biology	S Pan, Y Lei, T Wang, J Wynne, CW Chang, J Roper, AB Jani, P Patel, JD Bradley, T Liu, X Yang	10/14/2022
Randomized Trial of Conventional Versus Conventional Plus Fluciclovine (¹⁸F) Positron Emission Tomography/Computed Tomography-Guided Postprostatectomy Radiation Therapy for Prostate Cancer: Volumetric and Patient-Reported Analyses of Toxic Effects. International journal of radiation oncology, biology, physics	VR Dhere, DM Schuster, S Goyal, E Schreibmann, BW Hershatter, PJ Rossi, JW Shelton, PR Patel, AB Jani	08/01/2022
Treatment Patterns and Overall Survival Outcomes Among Patients Aged 80 yr or Older with High-risk Prostate Cancer. European urology open science	BW Fischer-Valuck, BC Baumann, SA Brown, CP Filson, A Weiss, R Mueller, Y Liu, RJ Brenneman, M Sanda, JM Michalski, HA Gay, Y James Rao, JG Pattaras, AB Jani, B Hershatter, SA Patel	03/01/2022
Association of race with receipt of definitive therapy for high risk prostate cancer in older men. Journal of geriatric oncology	SA Patel, Y Liu, BA Mahal, AB Jani, MG Sanda, TJ Royce, BW Fischer-Valuck	03/01/2022
Longitudinal Changes in U.S. Parameters of Neurovascular Bundles Suggest Mechanism for Radiation-Induced Erectile Dysfunction. Advances in radiation oncology	JR Janopaul-Naylor, T Liu, B Zhou, X Yang, NS McCall, PR Patel, A Mehta, SG Nour, AB Jani	01/01/2022
Bone Marrow Suppression during Postoperative Radiation for Bladder Cancer and Comparative Benefit of Proton Therapy-Phase 2 Trial Secondary Analysis. International journal of particle therapy	RH Press, JW Shelton, C Zhang, Q Dang, S Tian, T Shu, CS Seldon, S Hasan, AB Jani, J Zhou, MW McDonald	01/01/2022
Catheter position prediction using deep-learning-based multi-atlas registration for high-dose rate prostate brachytherapy. Medical physics	Y Lei, T Wang, Y Fu, J Roper, AB Jani, T Liu, P Patel, X Yang	11/01/2021
Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer Database. Clinical genitourinary cancer	KM Xu, Y Liu, TW Gillespie, AO Osunkoya, B Carthon, MA Bilen, CP Filson, K Ogan, PR Patel, JW Shelton, O Kucuk, S Joshi, AB Jani	08/01/2021
Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer. Clinical genitourinary cancer	TJ Royce, Y Liu, MI Milowsky, JA Efstathiou, AB Jani, B Fischer-Valuck, SA Patel	08/01/2021
Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on ¹⁸F-Fluciclovine PET/CT Guidance. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	OA Abiodun-Ojo, AB Jani, AA Akintayo, OO Akin-Akintayo, OA Odewole, FI Tade, SS Joshi, VA Master, B Fielder, RK Halkar, C Zhang, S Goyal, MM Goodman, DM Schuster	08/01/2021
Follow the Trials. International journal of radiation oncology, biology, physics	AB Jani	07/01/2021
Self-supervised learning for accelerated 3D high-resolution ultrasound imaging. Medical physics	X Dai, Y Lei, T Wang, M Axente, D Xu, P Patel, AB Jani, WJ Curran, T Liu, X Yang	07/01/2021
Early Comparative Toxicity Outcomes of Patients With Prostate Cancer Receiving Initial Cryotherapy and Radiotherapy Salvage. Clinical genitourinary cancer	C Jiang, K Godette, WA Hall, JK Bennett, P Rossi, S Cooper, AB Jani, PR Patel	06/01/2021
Overall Survival After Treatment of Localized Prostate Cancer With Proton Beam Therapy, External-Beam Photon Therapy, or Brachytherapy. Clinical genitourinary cancer	Y Liu, SA Patel, AB Jani, TW Gillespie, PR Patel, KD Godette, BW Hershatter, JW Shelton, MW McDonald	06/01/2021
Male pelvic multi-organ segmentation on transrectal ultrasound using anchor-free mask CNN. Medical physics	Y Lei, T Wang, J Roper, AB Jani, SA Patel, WJ Curran, P Patel, T Liu, X Yang	06/01/2021
Stereotactic body radiation therapy use for high risk prostate cancer in the United States. Prostate cancer and prostatic diseases	SA Patel, JM Switchenko, AU Kishan, AB Jani, TJ Royce, BW Fischer-Valuck	06/01/2021
¹⁸F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial. Lancet (London, England)	AB Jani, E Schreibmann, S Goyal, R Halkar, B Hershatter, PJ Rossi, JW Shelton, PR Patel, KM Xu, M Goodman, VA Master, SS Joshi, O Kucuk, BC Carthon, MA Bilen, OA Abiodun-Ojo, AA Akintayo, VR Dhere, DM Schuster	05/22/2021
Ring Sclerosis in Prostate Cancer: Circle of Malignancy or Benignity? Clinical nuclear medicine	C Marcus, Y Baum, OA Abiodun-Ojo, AB Jani, DM Schuster	05/01/2021
Male pelvic CT multi-organ segmentation using synthetic MRI-aided dual pyramid networks. Physics in medicine and biology	Y Lei, T Wang, S Tian, Y Fu, P Patel, AB Jani, WJ Curran, T Liu, X Yang	04/16/2021
Low Utilization of Androgen Deprivation Therapy Among Men Receiving Stereotactic Body Radiotherapy for Localized Prostate Cancer in the United States. European urology oncology	TJ Royce, JM Switchenko, C Zhang, DE Spratt, RC Chen, AB Jani, SA Patel	04/01/2021
Influence of Timing Between Androgen Deprivation Therapy and External Beam Radiation Therapy in Patients With Localized, High-Risk Prostate Cancer. Advances in radiation oncology	NS McCall, Y Liu, SA Patel, B Hershatter, D Moghanaki, KD Godette, S Hanasoge, P Patel, BW Fischer-Valuck, JW Shelton, AB Jani	01/01/2021
Clinical utility of ¹⁸F-Fluciclovine PET/CT in recurrent prostate cancer with very low (≤0.3 ng/mL) prostate-specific antigen levels. American journal of nuclear medicine and molecular imaging	C Marcus, OA Abiodun-Ojo, AB Jani, DM Schuster	01/01/2021
Exploratory study of ¹⁸F-fluciclovine pet/ct for response assessment to docetaxel in patients with metastatic castration-resistant prostate cancer. American journal of nuclear medicine and molecular imaging	AA Akintayo, MA Bilen, OA Abiodun-Ojo, O Kucuk, B Carthon, Z Chen, AB Jani, EE Parent, DM Schuster	01/01/2021
Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer. Brachytherapy	VR Dhere, BW Fischer-Valuck, S Goyal, Y Liu, TM Morgan, E Ghavidel, DM Moghanaki, BW Hershatter, PR Patel, AB Jani, KD Godette, PJ Rossi, SA Patel	01/01/2021
Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database. Clinical and translational radiation oncology	JR Janopaul-Naylor, J Zhong, Y Liu, C Zhang, AO Osunkoya, SS Joshi, MA Bilen, B Carthon, O Kucuk, LM Hartsell, J Shelton, AB Jani	01/01/2021
Biomechanically constrained non-rigid MR-TRUS prostate registration using deep learning based 3D point cloud matching. Medical image analysis	Y Fu, Y Lei, T Wang, P Patel, AB Jani, H Mao, WJ Curran, T Liu, X Yang	01/01/2021
Deformable MR-CBCT prostate registration using biomechanically constrained deep learning networks. Medical physics	Y Fu, T Wang, Y Lei, P Patel, AB Jani, WJ Curran, T Liu, X Yang	01/01/2021
American Society for Radiation Oncology Editorial: Rapidly Evolving Technologies Related to Imaging Strategies for Advanced Prostate Cancer. Practical radiation oncology	GS Bauman, AB Jani	01/01/2021
Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine (¹⁸F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer. International journal of radiation oncology, biology, physics	A Jani, E Schreibmann, S Goyal, H Raghuveer, B Hershatter, PJ Rossi, JW Shelton, PR Patel, KM Xu, M Goodman, V Master, SS Joshi, O Kucuk, B Carthon, MA Bilen, S Cooper, B Fielder, O Abiodun-Ojo, VR Dhere, DM Schuster	12/01/2020
Analysis of Radiation Facility Volume and Survival in Men With Lymph Node-Positive Prostate Cancer Treated With Radiation and Androgen Deprivation Therapy. JAMA network open	SA Patel, S Goyal, Y Liu, D Moghanaki, PR Patel, S Hanasoge, VR Dhere, JW Shelton, KD Godette, AB Jani, B Hershatter, BW Fischer-Valuck	12/01/2020
Automatic multi-needle localization in ultrasound images using large margin mask RCNN for ultrasound-guided prostate brachytherapy. Physics in medicine and biology	Y Zhang, Z Tian, Y Lei, T Wang, P Patel, AB Jani, WJ Curran, T Liu, X Yang	10/09/2020
Stereotactic body radiotherapy versus conventional/moderate fractionated radiation therapy with androgen deprivation therapy for unfavorable risk prostate cancer. Radiation oncology (London, England)	SA Patel, JM Switchenko, B Fischer-Valuck, C Zhang, BS Rose, RC Chen, AB Jani, TJ Royce	09/15/2020
Pelvic multi-organ segmentation on cone-beam CT for prostate adaptive radiotherapy. Medical physics	Y Fu, Y Lei, T Wang, S Tian, P Patel, AB Jani, WJ Curran, T Liu, X Yang	08/01/2020
Multi-Needle Detection in 3D Ultrasound Images Using Unsupervised Order-Graph Regularized Sparse Dictionary Learning. IEEE transactions on medical imaging	Y Zhang, X He, Z Tian, JJ Jeong, Y Lei, T Wang, Q Zeng, AB Jani, WJ Curran, P Patel, T Liu, X Yang	07/01/2020
Multi-needle Localization with Attention U-Net in US-guided HDR Prostate Brachytherapy. Medical physics	Y Zhang, Y Lei, RLJ Qiu, T Wang, H Wang, AB Jani, WJ Curran, P Patel, T Liu, X Yang	07/01/2020
Label-driven magnetic resonance imaging (MRI)-transrectal ultrasound (TRUS) registration using weakly supervised learning for MRI-guided prostate radiotherapy. Physics in medicine and biology	Q Zeng, Y Fu, Z Tian, Y Lei, Y Zhang, T Wang, H Mao, T Liu, WJ Curran, AB Jani, P Patel, X Yang	06/26/2020
Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	EJ Trabulsi, RB Rumble, H Jadvar, T Hope, M Pomper, B Turkbey, AB Rosenkrantz, S Verma, DJ Margolis, A Froemming, A Oto, A Purysko, MI Milowsky, HP Schlemmer, M Eiber, MJ Morris, PL Choyke, A Padhani, J Oldan, S Fanti, S Jain, PA Pinto, KA Keegan, CR Porter, JA Coleman, GS Bauman, AB Jani, JM Kamradt, W Sholes, HA Vargas	06/10/2020
A planning study of focal dose escalations to multiparametric MRI-defined dominant intraprostatic lesions in prostate proton radiation therapy. The British journal of radiology	T Wang, J Zhou, S Tian, Y Wang, P Patel, AB Jani, KM Langen, WJ Curran, T Liu, X Yang	03/01/2020
Male pelvic multi-organ segmentation aided by CBCT-based synthetic MRI. Physics in medicine and biology	Y Lei, T Wang, S Tian, X Dong, AB Jani, D Schuster, WJ Curran, P Patel, T Liu, X Yang	02/04/2020
CT prostate segmentation based on synthetic MRI-aided deep attention fully convolution network. Medical physics	Y Lei, X Dong, Z Tian, Y Liu, S Tian, T Wang, X Jiang, P Patel, AB Jani, H Mao, WJ Curran, T Liu, X Yang	02/01/2020
Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer. Brachytherapy	BW Fischer-Valuck, YJ Rao, RJ Brenneman, PR Patel, CP Filson, AB Jani, Y Liu, S Goyal, K Xu, A Weiss, O Kucuk, C Cimmino, S Szabo, P Rossi, BC Baumann, J Pattaras, B Hershatter, SA Patel	01/01/2020
Dose evaluation of MRI-based synthetic CT generated using a machine learning method for prostate cancer radiotherapy. Medical dosimetry : official journal of the American Association of Medical Dosimetrists	G Shafai-Erfani, T Wang, Y Lei, S Tian, P Patel, AB Jani, WJ Curran, T Liu, X Yang	12/01/2019
Dosimetric study on learning-based cone-beam CT correction in adaptive radiation therapy. Medical dosimetry : official journal of the American Association of Medical Dosimetrists	T Wang, Y Lei, N Manohar, S Tian, AB Jani, HK Shu, K Higgins, A Dhabaan, P Patel, X Tang, T Liu, WJ Curran, X Yang	12/01/2019
Synthetic MRI-aided multi-organ segmentation on male pelvic CT using cycle consistent deep attention network. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology	X Dong, Y Lei, S Tian, T Wang, P Patel, WJ Curran, AB Jani, T Liu, X Yang	12/01/2019
Videos improve patient understanding of misunderstood chemotherapy terminology. Cancer	RD Pentz, M Lohani, M Hayban, JM Switchenko, MD Dixon, RJ DeFeo, GM Orloff, AB Jani, VA Master	11/15/2019
Evaluation of a deep learning-based pelvic synthetic CT generation technique for MRI-based prostate proton treatment planning. Physics in medicine and biology	Y Liu, Y Lei, Y Wang, G Shafai-Erfani, T Wang, S Tian, P Patel, AB Jani, M McDonald, WJ Curran, T Liu, J Zhou, X Yang	10/21/2019
Role of novel imaging in the management of prostate cancer. Urologic oncology	KM Xu, RC Chen, DM Schuster, AB Jani	09/01/2019
MRI-only based synthetic CT generation using dense cycle consistent generative adversarial networks. Medical physics	Y Lei, J Harms, T Wang, Y Liu, HK Shu, AB Jani, WJ Curran, H Mao, T Liu, X Yang	08/01/2019
Ultrasound prostate segmentation based on multidirectional deeply supervised V-Net. Medical physics	Y Lei, S Tian, X He, T Wang, B Wang, P Patel, AB Jani, H Mao, WJ Curran, T Liu, X Yang	07/01/2019
Multiparametric MRI-guided dose boost to dominant intraprostatic lesions in CT-based High-dose-rate prostate brachytherapy. The British journal of radiology	T Wang, RH Press, M Giles, AB Jani, P Rossi, Y Lei, WJ Curran, P Patel, T Liu, X Yang	05/01/2019
Deeply supervised 3D fully convolutional networks with group dilated convolution for automatic MRI prostate segmentation. Medical physics	B Wang, Y Lei, S Tian, T Wang, Y Liu, P Patel, AB Jani, H Mao, WJ Curran, T Liu, X Yang	04/01/2019
The American Society for Radiation Oncology 2017 Radiation Oncologist Workforce Study. International journal of radiation oncology, biology, physics	CY Fung, E Chen, N Vapiwala, S Pohar, D Trifiletti, MT Truong, G Uschold, J Schuster, A Patel, A Jani, P Mohindra, T Sanders, L Gardner, A Arnone, T Royce	03/01/2019
A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526). International journal of radiation oncology, biology, physics	JM Crook, P Zhang, TM Pisansky, EJ Trabulsi, MB Amin, W Bice, G Morton, N Pervez, E Vigneault, C Catton, J Michalski, M Roach, D Beyer, A Jani, E Horwitz, V Donavanik, H Sandler	02/01/2019
Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation. American journal of clinical oncology	J Zhong, J Switchenko, NK Jegadeesh, RJ Cassidy, TW Gillespie, V Master, P Nieh, M Alemozaffar, O Kucuk, B Carthon, CP Filson, MA Bilen, AB Jani	01/01/2019
High-dose-rate prostate brachytherapy appears safe in patients with high baseline International Prostate Symptom Scores. Brachytherapy	TM Morgan, PJ Rossi, PK Cutrell, C Zhang, RH Press, S Rahnema, M Sanda, J Pattaras, C Cimmino, B Hershatter, AB Jani, PR Patel	01/01/2019
Patient-reported health-related quality of life outcomes after HDR brachytherapy between small (<60 cc) and large (≥60 cc) prostate glands. Brachytherapy	RH Press, TM Morgan, PK Cutrell, C Zhang, Z Chen, S Rahnema, M Sanda, J Pattaras, P Patel, AB Jani, PJ Rossi	01/01/2019
Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	JJ Coen, P Zhang, PJ Saylor, CT Lee, CL Wu, W Parker, T Lautenschlaeger, AL Zietman, JA Efstathiou, AB Jani, O Kucuk, L Souhami, JP Rodgers, HM Sandler, WU Shipley	01/01/2019
Brachytherapy for localized prostate cancer in the modern era: a comparison of patient-reported quality of life outcomes among different techniques. Journal of contemporary brachytherapy	TM Morgan, RH Press, PK Cutrell, C Zhang, Z Chen, S Rahnema, M Sanda, J Pattaras, PR Patel, AB Jani, PJ Rossi	12/01/2018
The addition of chemotherapy in the definitive management of high risk prostate cancer. Urologic oncology	MJ Ferris, Y Liu, J Ao, J Zhong, M Abugideiri, TW Gillespie, BC Carthon, MA Bilen, O Kucuk, AB Jani	11/01/2018
MRI-based pseudo CT synthesis using anatomical signature and alternating random forest with iterative refinement model. Journal of medical imaging (Bellingham, Wash.)	Y Lei, JJ Jeong, T Wang, HK Shu, P Patel, S Tian, T Liu, H Shim, H Mao, AB Jani, WJ Curran, X Yang	10/01/2018
Upcoming imaging concepts and their impact on treatment planning and treatment response in radiation oncology. Radiation oncology (London, England)	PR Roberts, AB Jani, S Packianathan, A Albert, R Bhandari, S Vijayakumar	08/13/2018
Magnetic resonance imaging-based pseudo computed tomography using anatomic signature and joint dictionary learning. Journal of medical imaging (Bellingham, Wash.)	Y Lei, HK Shu, S Tian, JJ Jeong, T Liu, H Shim, H Mao, T Wang, AB Jani, WJ Curran, X Yang	07/01/2018
Hypofractionated external beam radiation therapy in combination with HDR boost for localized prostate cancer: patient reported quality of life outcomes. Journal of contemporary brachytherapy	TM Morgan, RH Press, PK Cutrell, C Zhang, Z Chen, S Rahnema, J Jhaveri, M Sanda, J Pattaras, P Patel, AB Jani, PJ Rossi	06/01/2018
Prospective evaluation of fluciclovine (¹⁸F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients. European journal of radiology	O Akin-Akintayo, F Tade, P Mittal, C Moreno, PT Nieh, P Rossi, D Patil, R Halkar, B Fei, V Master, AB Jani, H Kitajima, AO Osunkoya, C Ormenisan-Gherasim, MM Goodman, DM Schuster	05/01/2018
Reproducibility in contouring the neurovascular bundle for prostate cancer radiation therapy. Practical radiation oncology	RJ Cassidy, SG Nour, T Liu, JM Switchenko, S Tian, MJ Ferris, RH Press, J Zhong, M Abugideiri, PJ Rossi, AB Jani	01/01/2018
Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology. CA: a cancer journal for clinicians	CG Ethun, MA Bilen, AB Jani, SK Maithel, K Ogan, VA Master	09/01/2017
Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology. Urologic oncology	RS Gerhard, D Patil, Y Liu, K Ogan, M Alemozaffar, AB Jani, ON Kucuk, VA Master, TW Gillespie, CP Filson	05/01/2017
Impact of ¹⁸F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	AB Jani, E Schreibmann, PJ Rossi, J Shelton, K Godette, P Nieh, VA Master, O Kucuk, M Goodman, R Halkar, S Cooper, Z Chen, DM Schuster	03/01/2017
The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer. Cancer	N Jegadeesh, Y Liu, C Zhang, J Zhong, RJ Cassidy, T Gillespie, O Kucuk, P Rossi, VA Master, M Alemozaffar, AB Jani	02/01/2017
Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer. Clinical nuclear medicine	OO Akin-Akintayo, AB Jani, O Odewole, FI Tade, PT Nieh, VA Master, LM Bellamy, RK Halkar, C Zhang, Z Chen, MM Goodman, DM Schuster	01/01/2017
Improved prostate delineation in prostate HDR brachytherapy with TRUS-CT deformable registration technology: A pilot study with MRI validation. Journal of applied clinical medical physics	X Yang, PJ Rossi, AB Jani, H Mao, Z Zhou, WJ Curran, T Liu	01/01/2017
Biomarkers of Outcome in Patients With Localized Prostate Cancer Treated With Radiotherapy. Seminars in radiation oncology	WA Hall, CA Lawton, AB Jani, A Pollack, FY Feng	01/01/2017
Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT. European journal of nuclear medicine and molecular imaging	OA Odewole, FI Tade, PT Nieh, B Savir-Baruch, AB Jani, VA Master, PJ Rossi, RK Halkar, AO Osunkoya, O Akin-Akintayo, C Zhang, Z Chen, MM Goodman, DM Schuster	09/01/2016
Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy. International journal of radiation oncology, biology, physics	BC Baumann, WR Bosch, A Bahl, AJ Birtle, RH Breau, A Challapalli, AJ Chang, A Choudhury, S Daneshmand, A El-Gayed, A Feldman, SE Finkelstein, TJ Guzzo, S Hilman, A Jani, SB Malkowicz, CA Mantz, V Master, AV Mitra, V Murthy, SP Porten, PM Richaud, P Sargos, JA Efstathiou, LJ Eapen, JP Christodouleas	09/01/2016
Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial. International journal of radiation oncology, biology, physics	E Schreibmann, DM Schuster, PJ Rossi, J Shelton, S Cooper, AB Jani	09/01/2016
In regard to Wu and Vapiwala et al. International journal of radiation oncology, biology, physics	JE Meyer, TJ Dilling, RJ Amdur, JF Strasser, R Tendulkar, WR Lee, AB Jani, M Elshaikh, MM Poppe, C Takita, A Currey, SK Cheng, R Jagsi, JV Kuo, AM Chen, AE Dragun, K Bradley, S Beriwal, RP Smith, RC Chen, K Rosenzweig, S Kim, K Mehta	03/15/2016
3D Transrectal Ultrasound (TRUS) Prostate Segmentation Based on Optimal Feature Learning Framework. Proceedings of SPIE--the International Society for Optical Engineering	X Yang, PJ Rossi, AB Jani, H Mao, WJ Curran, T Liu	01/01/2016
Patch-Based Label Fusion for Automatic Multi-Atlas-Based Prostate Segmentation in MR Images. Proceedings of SPIE--the International Society for Optical Engineering	X Yang, AB Jani, PJ Rossi, H Mao, WJ Curran, T Liu	01/01/2016
Bladder preservation strategies. Hematology/oncology clinics of North America	AB Jani, JA Efstathiou, WU Shipley	04/01/2015
Reproducibility and reliability of anti-3-[¹⁸F]FACBC uptake measurements in background structures and malignant lesions on follow-up PET-CT in prostate carcinoma: an exploratory analysis. Molecular imaging and biology	OA Odewole, OA Oyenuga, F Tade, B Savir-Baruch, PT Nieh, V Master, Z Chen, X Wang, AB Jani, LM Bellamy, RK Halkar, MM Goodman, DM Schuster	04/01/2015
Video-based educational tool improves patient comprehension of common prostate health terminology. Cancer	DS Wang, AB Jani, M Sesay, CG Tai, DK Lee, KV Echt, MG Goodman, KE Kilbridge, VA Master	03/01/2015
A 3D Neurovascular Bundles Segmentation Method based on MR-TRUS Deformable Registration. Proceedings of SPIE--the International Society for Optical Engineering	X Yang, P Rossi, AB Jani, H Mao, T Ogunleye, WJ Curran, T Liu	02/01/2015
A MR-TRUS Registration Method for Ultrasound-Guided Prostate Interventions. Proceedings of SPIE--the International Society for Optical Engineering	X Yang, P Rossi, H Mao, AB Jani, T Ogunleye, WJ Curran, T Liu	02/01/2015
Locoregional prostate cancer treatment pattern variation in independent cancer centers: policy effect, patient preference, or physician incentive? Health services insights	AS Camarata, DC Nickleach, AB Jani, PJ Rossi	01/01/2015
Results of the 2014 Survey of the Association of Directors of Radiation Oncology Programs (ADROP). Practical radiation oncology	AB Jani, D Marshall, N Vapiwala, SB Davis, M Langer	01/01/2015
Comparison of image-guided radiotherapy technologies for prostate cancer. American journal of clinical oncology	S Das, T Liu, AB Jani, P Rossi, J Shelton, Z Shi, MK Khan	12/01/2014
Prostate CT segmentation method based on nonrigid registration in ultrasound-guided CT-based HDR prostate brachytherapy. Medical physics	X Yang, P Rossi, T Ogunleye, DM Marcus, AB Jani, H Mao, WJ Curran, T Liu	11/01/2014
The impact of multiparametric pelvic magnetic resonance imaging on risk stratification in patients with localized prostate cancer. Urology	DM Marcus, PJ Rossi, SG Nour, AB Jani	07/01/2014
Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial. The Journal of urology	DM Schuster, PT Nieh, AB Jani, R Amzat, FD Bowman, RK Halkar, VA Master, JA Nye, OA Odewole, AO Osunkoya, B Savir-Baruch, P Alaei-Taleghani, MM Goodman	05/01/2014
A New CT Prostate Segmentation for CT-Based HDR Brachytherapy. Proceedings of SPIE--the International Society for Optical Engineering	X Yang, P Rossi, T Ogunleye, AB Jani, WJ Curran, T Liu	01/01/2014
The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. Cancer	WA Hall, DC Nickleach, VA Master, RS Prabhu, PJ Rossi, K Godette, S Cooper, AB Jani	09/15/2013
Severe lack of comprehension of common prostate health terms among low-income inner-city men. Cancer	DS Wang, AB Jani, CG Tai, M Sesay, DK Lee, M Goodman, KV Echt, KE Kilbridge, VA Master	09/01/2013
Influence of vascular comorbidities and race on erectile dysfunction after prostate cancer radiotherapy. The journal of sexual medicine	Y Wang, T Liu, PJ Rossi, D Watkins-Bruner, W Hsiao, S Cooper, X Yang, AB Jani	08/01/2013
Therapeutic options for a rising PSA after radical prostatectomy. The Canadian journal of urology	BC Carthon, DM Marcus, LA Herrel, AB Jani, PJ Rossi, DJ Canter	06/01/2013
Treatment efficiency of volumetric modulated arc therapy in comparison with intensity-modulated radiotherapy in the treatment of prostate cancer. Journal of the American College of Radiology : JACR	WA Hall, TH Fox, X Jiang, RS Prabhu, PJ Rossi, K Godette, AB Jani	02/01/2013
Clinically Significant Difference in Prostate Localization Using Daily Cone Beam CT (CBCT) and Electromagnetic Transponders. Practical radiation oncology	MK Khan, S Das, T Ogunleye, AB Jani, P Rossi, J Shelton, T Liu	01/01/2013
Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate. Practical radiation oncology	WA Hall, L Colbert, D Nickleach, J Shelton, DM Marcus, J Switchenko, PJ Rossi, K Godette, S Cooper, AB Jani	01/01/2013
Feasibility of accelerated partial breast irradiation in a large inner-city public hospital. Annals of surgical oncology	M Amin, S Gabram, H Bumpers, J Landry, AB Jani, R Diaz, M Rizzo	12/01/2012
A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008. Prostate cancer and prostatic diseases	DM Marcus, M Goodman, AB Jani, AO Osunkoya, PJ Rossi	09/01/2012
High-dose radiotherapy with or without androgen deprivation therapy for intermediate-risk prostate cancer: cancer control and toxicity outcomes. International journal of radiation oncology, biology, physics	S Edelman, SL Liauw, PJ Rossi, S Cooper, AB Jani	08/01/2012
Matched cohort analysis of outcomes of definitive radiotherapy for prostate cancer in human immunodeficiency virus-positive patients. International journal of radiation oncology, biology, physics	S Kahn, A Jani, S Edelman, P Rossi, K Godette, J Landry, C Anderson	05/01/2012
Toxicity analysis of dose escalation from 75.6 gy to 81.0 gy in prostate cancer. American journal of clinical oncology	N Xu, PJ Rossi, AB Jani	02/01/2011
Observations on prostate intrafraction motion and the effect of reduced treatment time using volumetric modulated arc therapy. Practical radiation oncology	J Shelton, PJ Rossi, H Chen, Y Liu, VA Master, AB Jani	01/01/2011
A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age. American journal of clinical oncology	BE Terakedis, PJ Rossi, SL Liauw, PA Johnstone, AB Jani	12/01/2010
American Radium Society 92nd Annual Meeting. Expert review of anticancer therapy	AB Jani, QT Le, JJ Michalski, R Sawaya, LD Wilson	08/01/2010
Stage IV prostate cancer: survival differences in clinical T4, nodal and metastatic disease. The Journal of urology	W Hsiao, KA Moses, M Goodman, AB Jani, PJ Rossi, VA Master	08/01/2010
Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program. Cancer	TV Johnson, W Hsiao, KA Delman, AB Jani, OW Brawley, VA Master	06/15/2010
A review of low-dose-rate prostate brachytherapy--techniques and outcomes. Journal of the National Medical Association	DM Marcus, AB Jani, K Godette, PJ Rossi	06/01/2010
Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis. American journal of clinical oncology	AB Jani, PA Johnstone, SL Liauw, VA Master, PJ Rossi	04/01/2010
Lymphadenectomy for patients with cervical cancer: is it of value? Journal of surgical oncology	PJ Rossi, IR Horowitz, PA Johnstone, AB Jani	10/01/2009
Influence of demographic factors on outcome of collecting duct carcinoma: a Surveillance, Epidemiology, and End Results (SEER) database analysis. Clinical genitourinary cancer	JM Pepek, PA Johnstone, AB Jani	08/01/2009
PET lesion segmentation using automated iso-intensity contouring in head and neck cancer. Technology in cancer research & treatment	E Simon, TH Fox, D Lee, AF Waller, P Pantalone, AB Jani	08/01/2009
Performance evaluation of Calypso 4D localization and kilovoltage image guidance systems for interfraction motion management of prostate patients. TheScientificWorldJournal	T Ogunleye, PJ Rossi, AB Jani, T Fox, E Elder	06/12/2009
Pelvic shape and prostate motion: implications for target volume design and analysis of acute toxicity. American journal of clinical oncology	AB Jani, TH Fox, D Blaustein, PJ Rossi, PA Johnstone, VA Master	06/01/2009
Case study of anti-1-amino-3-F-18 fluorocyclobutane-1-carboxylic acid (anti-[F-18] FACBC) to guide prostate cancer radiotherapy target design. Clinical nuclear medicine	AB Jani, TH Fox, D Whitaker, DM Schuster	05/01/2009
Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology	PJ Rossi, E Schreibmann, AB Jani, VA Master, PA Johnstone	03/01/2009
International collaborations in radiation oncology: a single-institution experience in academic outreach. Journal of the American College of Radiology : JACR	AB Jani, N Esiashvili, D Cassels, K Godette, PA Johnstone	09/01/2008
Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis. American journal of clinical oncology	AB Jani, PA Johnstone, SL Liauw, VA Master, OW Brawley	08/01/2008
Early prostate cancer: hedonic prices model of provider-patient interactions and decisions. International journal of radiation oncology, biology, physics	AB Jani, S Hellman	03/15/2008
Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis. International journal of radiation oncology, biology, physics	PJ Rossi, AB Jani, IR Horowitz, PA Johnstone	01/01/2008

Awards

ASTRO Junior Faculty Research Fellow Award/Grant - 2003-2005
ASTRO-ESTRO Travel Grant - 2002
Alpha Omega Alpha Honor Medical Society - Alpha of Illinois

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.9	One star One star One star One star One half star	Provider showed concern
4.9	One star One star One star One star One half star	Provider explained things clearly
4.9	One star One star One star One star One half star	Provider discussed treatment options
4.9	One star One star One star One star One half star	Provider included you in decisions
4.9	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	05/17/2025	Beyond words. Especially nice for family
One star One star One star One star One star	04/17/2025	The care providers are excellent
One star One star One star One star One star	04/07/2025	Care provider showed great attention to my questions or concerns. Conclusive advice on progress of my treatment was provided.
One star One star One star One star One star	04/03/2025	Excellent
One star One star One star One star One star	03/20/2025	Good
One star One star One star One star One star	03/05/2025	Dr. Jani was thorough, pleasant and friendly.
One star One star One star One star One star	02/25/2025	Top notch treatment.
One star One star One star One star One star	02/25/2025	I have full faith and confidence in Emory as an institution, the nurses, the doctors and all the radiation technicians!
One star One star One star One star One star	02/06/2025	So thankful to have such a caring and supportive provider.
One star One star One star One star One star	02/05/2025	Dr Jani and the doctor assisting him make this journey so much better. They are thorough and never rush you. They let me ask all my questions and gave me all the answers to my questions. A great team!
One star One star One star One star One star	01/30/2025	Good
One star One star One star One star One star	01/29/2025	My son was a patient at Emory oncology and was treated wonderfully making my choice to use Emory a no brainer
One star One star One star One star One star	01/29/2025	Of course
One star One star One star One star One star	01/10/2025	Excellent
One star One star One star One star One star	01/09/2025	Dr Jani and Dr Mo are great. Very thorough, listens to the patients and does not rush you out. Answers all questions. Outstanding providers.
One star One star One star One star One star	12/27/2024	Good
One star One star One star One star One star	12/18/2024	I researched my doctor before I arrived along with his reviews. He had excellent reviews and I understood why after the visit. He is very good and very knowledgeable and with the great bedside manner.
One star One star One star One star One star	12/17/2024	Very good
One star One star One star One star One star	12/01/2024	Good
One star One star One star One star One star	11/23/2024	Good
One star One star One star One star One star	11/15/2024	Good
One star One star One star One star One star	11/12/2024	I was very pleased with their attentiveness and patience
One star One star One star One star One star	11/08/2024	Great
One star One star One star One star One star	09/13/2024	Good experience
One star One star One star One star One star	08/24/2024	Emory Proton Center was recommended to me by a very good trusted friend and I would do the same going forward!!!
One star One star One star One star One star	08/09/2024	Dr. Jani was great! He was just a straightforward and professional as I expected.
One star One star One star One star One star	08/09/2024	Exceptional care
One star One star One star One star One star	07/28/2024	I live in SW Virginia and I would not go anywhere but Emory for my life saving medical needs. From kidney transplant, nephrectomy and three separate session of proton therapy.
One star One star One star One star One star	07/24/2024	Professional
One star One star One star One star One star	07/12/2024	Most impressed with service and professionalism of Dr Jani
One star One star One star One star One star	06/30/2024	Excellent doctor, maybe the best I've ever had!
One star One star One star One star One star	06/14/2024	Good